These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 16649221
1. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy. Secin FP, Bianco FJ, Vickers AJ, Reuter V, Wheeler T, Fearn PA, Eastham JA, Scardino PT. Cancer; 2006 Jun 01; 106(11):2369-75. PubMed ID: 16649221 [Abstract] [Full Text] [Related]
2. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. Eggener SE, Roehl KA, Smith ND, Antenor JA, Han M, Catalona WJ. J Urol; 2005 Apr 01; 173(4):1150-5. PubMed ID: 15758725 [Abstract] [Full Text] [Related]
4. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P. Eur Urol; 2009 May 01; 55(5):1003-11. PubMed ID: 19211184 [Abstract] [Full Text] [Related]
5. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Urology; 2004 Jul 01; 64(1):84-9. PubMed ID: 15245941 [Abstract] [Full Text] [Related]
8. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML. J Urol; 2007 Oct 01; 178(4 Pt 1):1311-5. PubMed ID: 17698095 [Abstract] [Full Text] [Related]
9. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. J Urol; 2007 Sep 01; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [Abstract] [Full Text] [Related]
10. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Urology; 2004 Oct 01; 64(4):749-53. PubMed ID: 15491714 [Abstract] [Full Text] [Related]
12. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A. BJU Int; 2011 Jun 01; 107(11):1755-61. PubMed ID: 20942833 [Abstract] [Full Text] [Related]
13. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status. Masterson TA, Pettus JA, Middleton RG, Stephenson RA. Urology; 2005 Jul 01; 66(1):152-5. PubMed ID: 15992904 [Abstract] [Full Text] [Related]
18. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Sankin A, Tareen B, Lepor H. Prostate Cancer Prostatic Dis; 2009 Apr 15; 12(2):204-8. PubMed ID: 19238170 [Abstract] [Full Text] [Related]
19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA. BJU Int; 2006 Jan 15; 97(1):51-5. PubMed ID: 16336328 [Abstract] [Full Text] [Related]
20. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI. Cancer; 2008 Mar 15; 112(6):1254-63. PubMed ID: 18286530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]